These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15185782)

  • 1. Glucose monitoring for diabetic patients using icodextrin.
    Wang R; Skoufos L; Martis L
    Perit Dial Int; 2004; 24(3):296-7. PubMed ID: 15185782
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of interference of icodextrin on creatinine measurements.
    Burke RA; Hughes G; Moberly JB
    Adv Perit Dial; 1999; 15():234-7. PubMed ID: 10682109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive interference of icodextrin metabolites in some enzymatic glucose methods.
    Janssen W; Harff G; Caers M; Schellekens A
    Clin Chem; 1998 Nov; 44(11):2379-80. PubMed ID: 9799776
    [No Abstract]   [Full Text] [Related]  

  • 4. Dialysis patient safety: safeguards to prevent iatrogenic hypoglycemia in patients receiving icodextrin.
    Sloand JA
    Am J Kidney Dis; 2012 Oct; 60(4):514-6. PubMed ID: 22835903
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel approaches to prescribing icodextrin.
    Blake PG
    Perit Dial Int; 2009; 29(4):412-4. PubMed ID: 19602606
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure.
    Basile C; Chimienti D; Bruno A; Cocola S; Libutti P; Teutonico A; Cazzato F
    Perit Dial Int; 2009; 29(1):116-8. PubMed ID: 19164263
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding the variability in ultrafiltration obtained with icodextrin.
    Lambie M; Stompor T; Davies S
    Perit Dial Int; 2009; 29(4):407-11. PubMed ID: 19602605
    [No Abstract]   [Full Text] [Related]  

  • 8. Icodextrin increases natriuretic peptides in diabetic patients undergoing CAPD.
    Bouchi R; Babazono T; Inoue A; Tanaka M; Tanaka N; Hase M; Ishii A; Iwamoto Y
    Perit Dial Int; 2006; 26(5):604-7. PubMed ID: 16973520
    [No Abstract]   [Full Text] [Related]  

  • 9. Significant intra- and interpatient variation in ultrafiltration achieved by icodextrin in APD patients.
    Liakopoulos V; Zarogiannis S; Eleftheriadis T; Dovas S; Stefanidis I
    Perit Dial Int; 2007; 27(1):97-8. PubMed ID: 17179521
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of icodextrin-based dialysis solution on peritoneal leptin clearance.
    Opatrná S; Opatrný K; Racek J; Sefrna F
    Perit Dial Int; 2003; 23(1):89-91. PubMed ID: 12691516
    [No Abstract]   [Full Text] [Related]  

  • 11. Ten years after MIDAS: icodextrin lights and shadows.
    Amici G; Da Rin G; Agostini A; Velo S; Bocci C
    Contrib Nephrol; 2003; (140):76-81. PubMed ID: 12800346
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
    Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
    Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis.
    Paniagua R; Orihuela O; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Prado-Uribe MD; Alcántara G; Amato D
    Kidney Int Suppl; 2008 Apr; (108):S125-30. PubMed ID: 18379535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH).
    de Moraes TP; Andreoli MC; Canziani ME; da Silva DR; Caramori JC; Ponce D; Cassi HV; de Andrade Bastos K; Rio DR; Pinto SW; Filho SR; de Campos LG; Olandoski M; Divino-Filho JC; Pecoits-Filho R
    Nephrol Dial Transplant; 2015 Nov; 30(11):1905-11. PubMed ID: 26063787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of icodextrin on the peritoneal membrane. An inaccurate comment.
    Gotloib L
    Nephrol Dial Transplant; 2010 Sep; 25(9):3125-6; author reply 3126. PubMed ID: 20576721
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence-based medicine in peritoneal dialysis: peritoneal dialysis solutions.
    Feriani M
    Contrib Nephrol; 2003; (140):202-8. PubMed ID: 12800361
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of exchange-free periods alternating with daily exchanges of icodextrin in the initial treatment of peritoneal dialysis-associated peritonitis: a safety study.
    Yehia M; Muyoma G; Topley N; Collins JF
    Perit Dial Int; 2014; 34(7):810-3. PubMed ID: 25520490
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycation and advanced glycation end-product formation with icodextrin and dextrose.
    Dawnay AB; Millar DJ
    Perit Dial Int; 1997; 17(1):52-8. PubMed ID: 9068023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis.
    Woodrow G; Stables G; Oldroyd B; Gibson J; Turney JH; Brownjohn AM
    Nephrol Dial Transplant; 1999 Jun; 14(6):1530-5. PubMed ID: 10383020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icodextrin's effects on peritoneal transport.
    Krediet RT; Ho-dac-Pannekeet MM; Imholz AL; Struijk DG
    Perit Dial Int; 1997; 17(1):35-41. PubMed ID: 9068020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.